CClinicalTrials.gg
Status unknownNCT00543036Updated Oct 12, 2007

Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction

A Phase 1/2 interventional study of H-Coil deep TMS in Marijuana Abuse, sponsored by Shalvata Mental Health Center. Status unknown at 1 site in Israel. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2007-10-12.

Sponsored by Shalvata Mental Health Center · Phase 1/2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2007), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 1/2
Study type
Interventional
Allocation
Randomized
Ages
21 Years to 70 Years
Sex
All
01

Study summary

Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week treatment trial for cannabis addiction as assessed by measures of drug intake and craving.

02

Conditions studied

  • Marijuana Abuse

Browse trials for

Keywords

  • Cannabis
  • Addiction
  • Craving
  • TMS
03

In context

Marijuana Abuse

517 studies on the registry are indexed under Marijuana Abuse; 114 are open to participants now.

Browse Marijuana Abuse studies →

Lead sponsor

Shalvata Mental Health Center is the lead sponsor of 73 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male and Female, aged 21-70 years, who meet DSM-IV TR diagnostic criteria for cannabis abuse and are motivated to quit cannabis use as assessed in the screening visit and gave their written informed consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • History of a primary major psychiatric other then cannabis abuse, or cognitive disorder according to DSM-IV TR criteria.
  • Hamilton depression scale rated 25 and above (moderate to severe depression)
  • Current alcohol or other substance abuse or dependence
  • Alcohol or other substance abuse or dependence during the last 12 months before recruitment.
  • History of or evidence of significant brain malformation,neoplasm, head injury, cerebral vascular events,neurodegenerative disorder or brain surgery.
  • Severe somatic co-morbidity
  • History of seizures Cardiac pace maker or other electronic implants Pregnancy and lactation
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)

Interventions

  • DeviceH-Coil deep TMS
06

Study locations

1 of 1 sites recruiting
  • Shalvata Mental Health Center
    Hod-HaSharon, 45100, Israel
    • Ziv Carmel, M.D · Contact · zivca@clalit.org.il · +972-9-7478570
    • Ziv Carmel, M.D · Principal investigator
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 12, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00543036
Lead sponsor
Shalvata Mental Health Center
First posted
Oct 12, 2007
Last update
Oct 12, 2007

Study contacts

Ziv Carmel, M.D.
Contact
zivca@clalit.org.il
+972-9-7478570
Ziv Carmel, M.D
principal investigator · Shalvata MHC affiliated to Tel-Aviv universtiy, Sackler school of medicine
Abraham Zangen, Ph.D.
principal investigator · Weizmann Institute, Rehovot, Israel
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion